BLUE BLUE

bluebird bio Stock Price

7.47
-0.02 (-0.27%)
Upgrade to Real-Time
Afterhours (Closed)
7.47
Volume 2,119,118
Bid Price 6.84
Ask Price 8.11
News -
Day High 7.87

Low
2.865

52 Week Range

High
11.70

Day Low 7.46
Company Name Stock Ticker Symbol Market Type
bluebird bio Inc BLUE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02 -0.27% 7.47 00:00:12
Open Price Low Price High Price Close Price Prev Close
7.87 7.46 7.87 7.49 7.49
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
14,766 2,119,118 $ 7.63 $ 16,163,312 - 2.865 - 11.70
Last Trade Time Type Quantity Stock Price Currency
19:36:01 1 $ 7.47 USD

Period:

Draw Mode:

bluebird bio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 619.34M 82.91M 62.04M $ 3.66M $ - -11.89 -1.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 121.52k 1.90%

more financials information »

bluebird bio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BLUE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week7.448.587.408.123,124,1660.030.4%
1 Month6.958.586.487.623,205,7400.527.48%
3 Months6.968.585.146.605,407,8840.517.33%
6 Months3.738.582.925.557,736,7763.74100.27%
1 Year9.8911.702.8655.675,124,342-2.42-24.47%
3 Years82.8799.362.86518.262,588,011-75.40-90.99%
5 Years221.55236.16712.86537.751,853,047-214.08-96.63%

bluebird bio Description

bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.